Form 4: Enfusion Director and 10% Owner, Bradford E. Bernstein, Reports Disposal of Shares Following Merger with Clearwater Analytics

Bradford E. Bernstein, a director and 10% owner of Enfusion, Inc., reported the disposal of 32,440,463 shares of Class A Common Stock due to the merger with Clearwater Analytics Holdings, Inc.

Summary

• Bradford E. Bernstein, a director and 10% owner of Enfusion, Inc., filed a Form 4 indicating changes in beneficial ownership.
• The filing reports the disposal of 32,440,463 shares of Class A Common Stock on April 21, 2025, due to the merger agreement with Clearwater Analytics Holdings, Inc.
• Under the merger agreement, each eligible share of Enfusion's Class A common stock was converted into the right to receive cash, shares of Clearwater Analytics' Class A common stock, or a combination thereof.
• Bernstein ceased to be the beneficial owner of any shares of Enfusion's Common Stock as a result of the merger.
• The filing also notes that Bernstein is the managing partner of FTV Capital, which holds 31,297,606 shares through FTV IV, L.P. and 1,142,857 shares through FTV Investment Holdings, L.P., but he disclaims beneficial ownership except to the extent of his pecuniary interest.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing related to a merger. It doesn't convey strong positive or negative sentiment, but rather reports a factual event.

Future Outlook

The document does not contain specific forward-looking statements beyond the completion of the merger.

Industry Context

This announcement reflects a consolidation trend within the financial technology sector, where companies are merging to expand their service offerings and market reach. Clearwater Analytics' acquisition of Enfusion is likely aimed at strengthening its position in the investment management solutions market.

Stakeholder Impact

• Shareholders of Enfusion received consideration in the form of cash, Clearwater Analytics shares, or a combination thereof.
• The merger may impact employees of both Enfusion and Clearwater Analytics due to potential synergies and restructuring.

Key Dates

Keywords

Enfusion, Clearwater Analytics, Merger, Form 4, Beneficial Ownership, Bernstein, Shares, FTV Capital